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An acute tick-borne rickettsiosis caused by Rickettsia
heilongjiangensis was diagnosed in 13 patients from the
Russian Far East in 2002. We amplified and sequenced
four portions of three rickettsial genes from the patients’
skin biopsy results and blood samples and showed that the
amplified rickettsial genes belong to R. heilongjiangensis,
which was recently isolated from Dermacentor sylvarum
ticks in nearby regions of China. This rickettsia, belonging
to subgroup of R. japonica, was previously suggested to be
pathogenic for humans on the basis of serologic findings.
We tested serum samples with different rickettsial antigens
from 11 patients and confirmed increasing titers of
immunoglobulin (Ig) G and IgM to spotted fever group rick-
ettsiae, including R. heilongjiangensis. Clinical and epi-
demiologic data on these patients show that this disease is
similar to other tick-borne rickettsioses. 
R
ussian Far East is a geographic, economic, and politi-
cal unit within the Russian Federation. It consists of
the smaller administrative areas (regions) located on or
close to the Asian Pacific coast. The southern portion of
Khabarovsk region, where this study was carried out, is sit-
uated alongside the Amur River down to the sea (Figure 1)
and is characterized by peculiar combinations of subtropi-
cal and boreal biologic niches. Local experience suggests
that tick-borne encephalitis, Siberian tick typhus, and,
more recently, Lyme disease are prevalent in this territory,
with marked seasonal disease peaks (1). In 2002, serolog-
ic evidence for acute granulocytic ehrlichiosis was found
in the region (2).
In 1932, a disease described as tick-borne fever (tick
typhus) was identified in the Russian Far East (3). In
Central Siberia in 1935, the agent of tick-borne fever,
Rickettsia sibirica, was isolated and described (4–6), and
several rickettsial isolates from the ticks from the Far
Eastern Russia have also been identified as this new
species (7). Since 1935, the cause of acute tick-borne spot-
ted fever in the Russian Far East (including Khabarovsk
Region) is thought to be R. sibirica, and the antigen of R.
sibirica has been used for serologic studies in clinical lab-
oratories. Nevertheless, differences between clinical pic-
tures of tick-borne fever and differences in serologic
cross-reactivity of sera from patients with tick-borne rick-
ettsiosis have been reported in Siberia and the Russian Far
East (8). Dermacentor sylvarum ticks have been identified
as a vector. In 1990s, several strains of R. sibirica were
also isolated from ticks in Primorye Region, south of
Khabarovsk Region (9). 
In Siberia and China, several new rickettsiae were
found.  R. mongolotimonae found in Inner Mongolia is
closely related to R. sibirica (10) and causes acute disease
in humans. Clinical cases have now been described in
France (11,12). R. heilongjiangensis (strain 054) was first
isolated from D. sylvarum ticks collected around Suifenhe
in the Heilongjiang Province of China in 1982 (13).
Serologic studies indicated that the organism was the prob-
able cause of an acute tick-borne disease in humans (14).
R. hulinensis (strain HL-93) was isolated in 1993 from
Haemaphysalis concinna ticks collected in Hulin County,
Heilongjiang Province (10). The pathogenicity of this
agent in humans is unknown. By using molecular evolu-
tionary genetic analyses, these rickettsiae were shown to
form a well-defined clade distinct from other spotted fever
group rickettsiae, including R. japonica (15). Both D. syl-
varum and H. concinna ticks inhabit the Russian Far East,
although D. sylvarum is quite rare (1). In this study, we
identify the cause of an acute, febrile, tick-transmitted dis-
ease in the Russian Far East and describe the clinical pic-
ture in these cases. 
RESEARCH
Acute Tick-borne Rickettsiosis
Caused by Rickettsia 
heilongjiangensis in 
Russian Far East
Oleg Y. Mediannikov,*†‡ Yuri Sidelnikov,† Leonid Ivanov,§ Eugenia Mokretsova,† 
Pierre-Edouard Fournier,‡ Irina Tarasevich,* and Didier Raoult‡
810 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 5, May 2004
*Gamaleya Research Institute of Epidemiology and Microbiology,
Moscow, Russia; †Far Eastern State Medical University,
Khabarovsk, Russia; ‡Université de la Méditerranée, Marseille,
France; and §Khabarovsk Plague Control Station of Ministry of
Health of Russian Federation, Khabarovsk, RussiaPatients and Methods
Sample Collection
During this study in 2002, we screened almost all
patients who were suspected clinically to have a tick-borne
rickettsiosis and who were hospitalized in the infectious
diseases department of Khabarovsk Municipal Hospital
No.10. Five to 20 days before onset of the disease, most
patients reported tick bites or tick exposure. Some had typ-
ical eschars on the skin without a history of a tick bite. The
illness was acute, febrile, and usually involved a macular
or maculopapular rash. All patients were successfully
treated with a 14-day course of doxycycline. Patients with
clinically evident features of tick-borne encephalitis (neu-
rologic signs) or Lyme disease (erythema migrans) were
excluded from the study. In total, samples from 65 patients
were investigated, 64 blood samples and 17 skin biopsy
results. Paired sera from most of the patients were tested
with conventional serologic methods. The first serum sam-
ple was taken immediately after admission to the hospital,
usually 1–9 days after the onset of the disease. The second
serum sample was taken 4–18 days later.
DNA Extraction, PCR, and Sequencing
Buffy coats were separated from fresh blood specimens
immediately after collection at patient’s admission. DNA
was extracted from the buffy coat and skin biopsies sam-
ples with QIAmp DNABlood Mini Kit and DNeasyTissue
Kit (Qiagen, Tokyo, Japan) according to manufacturer’s
instructions. 
Oligonucleotide primers used in this study and anneal-
ing temperatures are shown in Table 1. We used the nested
polymerase chain reaction (PCR) method for primary
detection of the rickettsial DNA in human samples. The
gltA (citrate synthase) gene was chosen as the target for
amplification because of its genus specificity and conserv-
ativeness. The primer CS1d (16), which is used tradition-
ally to amplify the full-length gltA gene, is complementary
to the ultimate 5′-end of the open reading frame for this
gene of R. prowazekii. Since we expected to find DNA of
the spotted fever group rickettsiae, we modified the primer
to be completely homologous to the corresponding portion
of the gene of R. conorii (Table 1). R. conorii has been
chosen as a template to design primer CS2d as the only
spotted fever group rickettsia having a completely
sequenced genome at the time of investigation.
Comparison of these two primers indicated that the newly
designed primer (CS2d) was at least 100 times more sensi-
tive than CS1d in the amplification of the serially diluted
DNAof R. montanensis, which was used as a positive con-
trol (data not shown). Primers CS2d and CSendR amplify
the full-length of the gltA gene. Primers CS877f and
CS1258r were used in the nested PCR assay. To amplify
the full-length of the gltA gene, we used PCR followed by
hemi-nested PCR using the product of the first PCR as a
template. Two conservative regions of the outer membrane
protein A (ompA) gene were amplified (base positions
91–680 and 3,608–6,789 with respect to the sequence pub-
lished for R. rickettsii) by using previously described
primers (17). Initial amplification of the 3,182-bp longer
region was achieved with primers 190-3588f and 190-
5044r and with primers 190-4859f and 190-6808r.
Products of this reaction were used later in the nested and
hemi-nested PCR reactions with corresponding primers.
The ompB gene was amplified from clinical samples and
DNA by using standard primers (18), except for the ulti-
mate forward primer 120-M59, which was found to pro-
duce nonspecific amplicons with the human DNA in
clinical samples. Instead, for clinical specimens, we used a
newly designed primer, 120-M36. As with the ompA, the
DNA from clinical samples was amplified in two steps. In
the first step, we amplified two halves of the gene, with a
small overlapping region with primers 120-M36 with 120-
2988 and 120-2788 with 120-4879. The products of these
reactions were used as templates for each of the specific
nested or heminested reactions for seven regions. All
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Figure 1. Geographic location
of study area.primers were purchased from Eurogentec (4102 Seraing,
Belgium).
Amplification has been carried out by routine methods
in a final volume of 50 µL with appropriate negative con-
trols (10,17). In all reactions, as a positive control, we used
a mixture of DNA of the following microorganisms:
Anaplasma phagocytophilum,  Neorickettsia sennetsu,
Wolbachia pipientis,  Francisella tularensis,  Bartonella
henselae, Borrelia garinii, Coxiella burnetii, and R. mon-
tanensis. We found that the cocktail of DNA of tick-borne
or phylogenetically close to tick-borne bacteria is conven-
ient to use in PCR with potentially polyinfected human
samples. 
We checked all samples for other possible tick-borne
bacterial and pathogens with the following primers under
conditions suggested in published references: SL primers
for  ospA gene of Borrelia (19); BhCS.781p and
BhCS.1137n primers for Bartonella citrate synthase (20);
HE1, HE3, and HE4 primers for 16S rDNA of Ehrlichia
chaffeensis (21); GE3A, GE10r, GE9f, and GE2 primers
for 16S rRNA gene of A. phagocytophilum (22); and
P3708 and p4257 primers for the gene encoding p44 pro-
tein of A. phagocytophilum (23) [data not shown]. No pos-
itive results have been obtained among patients described
here. 
The PCR products were purified for DNA sequencing
with the QIAquick PCR purification kit (Qiagen) and then
directly sequenced by using PCR primers. Sequencing
reactions were carried out with a D-rhodamine terminator
cycle DNA sequencing kit (Applied Biosystems, Foster
City, CA) according to the manufacturer’s instructions.
Sequencing reaction products were resolved by elec-
trophoresis with an ABI Prism 377 sequencer (Applied
Biosystems). The results obtained were processed into
sequence data with AutoAssembler software (Applied
Biosystems). The sequences of the gltA, both regions of
the ompA gene, and the ompB genes were aligned by using
the software Genetix-Win 5.1 (Software Development Co.,
Ltd., Japan). Sequences in the ompB genes of R. hei-
longjiangensis and R. hulinensis were not available in the
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Table 1. List of the primers used to detect rickettsial DNA 
Gene for amplification  Primer name  Primer sequence 5′-3′
a  Annealing temperature 
CS1d  ATGACTAATGGCAATAATAA   
CS2d  ATGACCAATGAAAATAATAAT  50°C 
CSEndr  CTTATACTCTCTATGTACA   
RpCS877p  GGGGACCTGCTCACGGCGG  54°C 
gltA 
RpCS1258n  ATTGCAAAAAGTACAGTGAACA   
190-70  ATGGCGAATATTTCTCCAAAA  ompA, 5′- portion 
190-701  GTTCCGTTAATGGCAGCATCT 
53°C 
190-3588f  AACAGTGAATGTAGGAGCAG 
190-3968r  TAGCAGCTGATTTAGTAGCT 
190-4084f  CATCACCGATATTTCTAGC 
190-4338f  TTCAGGAAACGACCGTACG 
190-4406r  ACTATACCCTCATCGTCATT 
190-4859f  GCGAAATCCAAGGTACAGG 
190-5044r  AACTTGTAGCACCTGCCGT 
190-5125f  GCGGTTACTTTAGCCAAAGG 
190-5238r  ACTATTAAAGGCTAGGCTATT 
190-5768f  CACCGCTACAGGAAGCAGAT 
190-5831r  GTGTCGCTAGGTTTTACAAC 
190-6228f  CGTTGAAGTATAGCATC 
190-6427r  ATCTAAGCCCAGCTAGCGGT 
ompA, 3′- portion 
190-6808r  CACGAACTTTCACACTACC 
46°C for the first round 50°C for 
the nested and heminested rounds 
120-M36  TTCTACAGCTACCATAGTAGCCA 
120-607  AATATCGGTGACGGTCAAGG 
120-807  CCTTTTAGATTACCGCCTAA 
120-1378  TAAACTTGCTGACGGTACAG 
120-1497  CCTATATCGCCGGTAATT 
120-2113  CGATGCTAACGTAGGTTCTT 
120-2339  CTTGTTTGTTTAATGTTACGGT 
120-2778  AAACAATAATCAAGGTACTGT 
120-2988  CCGGCTATACCGCCTGTAGT 
120-3462  CCACAGGAACTACAACCATT 
120-3599  TACTTCCGGTTACAGCAAAGT 
120-4232  GGTTTCTCATTCTCTCTATATGG 
120-4346  CGAAGAAGTAACGCTGACTT 
ompB 
120-4879  TTAGAAGTTTACACGGACTTTT 
50°C 
aDifferences between primers CS1d and CS2d are indicated by bold letters. GenBank database so we amplified and sequenced the
gene. The sequences used for comparison were obtained
from the GenBank database, aligned, and then corrected
manually to preserve codon alignment and conserved
motifs. Sites with ambiguous alignments were removed
before phylogenetic analysis. The phylogenetic tree was
calculated by using neighbor-joining method with MEGA2
Version 2.1 software (available from http://megasoft-
ware.net). Internal node support was verified by using the
bootstrap method with 100 replicates. 
Serologic Studies 
Two serologic tests were performed in Khabarovsk
Plague Control Station: immunofluorescence studies with
a combined antigen consisted of two local strains of B.
garinii and one local strain of B. afzelii, and an enzyme-
linked immunosorbent assay detected antibodies against
tick-borne encephalitis virus (24). For further investiga-
tions, sera were dried on blotting papers as described pre-
viously (25) and transported to Marseilles, where
microimmunofluorescence testing (26) was performed by
using in-house prepared antigens of R. heilongjiangensis
(strain 054, ATCC VR-1524), R. hulinensis (strain HL-93,
ATCC VR-1527), R. sibirica (strain 246, ATCC VR-151),
R. conorii (strain Moroccan ATCC VR-141), C. burnetii
(strain Nine Mile, ATCC VR-615), Orientia tsutsugamushi
(strains Gilliam, Karp, Kato, and Kawazaki), E. chaffeen-
sis (strain Arkansas), A. phagocytophilum (strain Webster),
Bartonella henselae (Houston-1, ATCC-49882), and B.
quintana (strain Oklahoma). Antigens were applied by pen
point to 18-well microscope slides, dried for 30 min, and
fixed. Appropriate positive- and negative-control serum
samples were tested on each slide together with twofold
dilutions of patients’ serum samples made in 3% nonfat
dry milk in phosphate-buffered saline (PBS). Slides were
incubated in a moist chamber for 30 min at 37°C, washed
twice in PBS and once in distilled water (10 min each);
reactive antibodies showed fluorescein isothiocyanate–
conjugated goat anti-human γ chain and µ-chain
immunoglobulins (BioMérieux, Marcy l’Etoile, France).
After the conjugate was added, slides were incubated for
30 min at 37°C, washed in two PBS for 10 min and for 5
min in distilled water, and mounted in buffered glycerol.
Endpoints for each antigen were the lowest concentrations
of serum that definitely conferred fluorescence on bacteria. 
Nucleotides Accession Numbers
Nucleotide sequences obtained during this study were
deposited in GenBank under the following numbers:
AY260451 for ompB gene of R. heilongjiangensis, strain
054; AY260452 for ompB gene for R. hulinensis;
AY280712 for ompB gene; AY280711 for previously
tandemly repeated region portion of ompA gene;
AY280710 for another portion; and AY280709 for gltA
gene of Rickettsia heilongjiangensis found in this study.
Results
We amplified and sequenced DNA of R. heilongjian-
gensis in samples from 16 patients. Serum samples from
11 were available for serologic studies, and clinical and
epidemiologic data have been analyzed for 13 patients,
including all patients with investigated serum samples.
Ten of 17 samples of DNA extracted from skin eschars
and seven of 64 samples of DNA extracted from buffy
coats were positive in the nested PCR for the gltA gene. In
one patient, both the skin biopsy and the buffy coat were
positive and had the same DNAsequence. Because we had
limited amounts of extracted DNA, we attempted to ampli-
fy both the ompA and ompB genes from six samples (three
skin biopsies and three blood samples), which were previ-
ously positive in nested PCR with primers for citrate syn-
thase gene. All positive samples were also screened by
PCR for other possible bacterial tick-borne pathogens and
were found to be negative. Results from testing, serologic
or PCR, that suggested double infection were excluded
from the study. Clinical picture of the disease was ana-
lyzed in patients with R. heilongjiangensis infection to
describe the disease associated with this organism.
All 17 nested PCR amplicons of amplified gltA gene
were directly sequenced and showed 100% homology. Six
amplicons of ompA and  ompB genes of corresponding
samples were also identical with each other. We obtained
full-length  gltA gene sequence, 590 bp and 3,182 bp
(excluding primer sequences) of 5′- and 3′-regions of the
ompA gene, respectively, and a 4,852-bp length sequence
of the ompB gene. A BLAST search showed that all
sequences were completely homologous to correspondent
genes of R. heilongjiangensis. Figure 2 shows the phyloge-
netic relationships of this Rickettsia  and other species
based on the analysis of both concatenated portions of the
ompA gene.
Serum samples from 11 of 16 patients were studied;
data are presented in Tables 2 and 3. None of the samples
had serologic evidence of any other nonrickettsial acute,
tick-borne disease. One previously vaccinated patient had
a low titer of immunoglobulin (Ig) G against tick-borne
encephalitis virus, and two had low titers to both B. hense-
lae and B. quintana (data not shown). In 9 of 11 available
paired sera from PCR-positive patients, we found serolog-
ic evidence for acute rickettsial infection, e.g., the presence
of IgM antibodies, seroconversion, or a fourfold rise in
antibody titer against rickettsial antigens. In samples from
two patients, IgG and IgM antibody titers to R. hei-
longjiangensis were highest. In samples from five patients,
the same titers were present against R. conorii and R. hei-
longjiangensis. In samples from one patient, we found the
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of antibodies against R. sibirica in all cases, except one,
were lower than against R. heilongjiangensis.  In four
of nine cases, titers were identical against antigens of R.
hulinensis and R. sibirica. Absence of specific antibodies
against rickettsiae in patients 2 and 3 could be explained
either by early treatment with a specific antimicrobial drug
or probable errors in serum sample collection and treat-
ment.
Epidemiologic, clinical, and laboratory data available
in 13 of 16 PCR-positive patients are given in Table 4.
Before the onset of the disease in the summer 2002 (from
June to August), all patients had a history of tick bite, tick
exposure, or a stay in an epidemiologically suspected loca-
tion. After an incubation period of 4 to 7 days, the patient
had a sudden onset with fever, but no specific symptoms
appeared during the first several days. In 12 patients, a
macular or maculopapular rash appeared but was usually
faint. Twelve patients had a primary lesion (eschar) at the
site of tick attachment (Figure 3). The eschar consisted of
a necrotic central region (50–150 mm in diameter) sur-
rounded by infiltrated and inflamed tissue (70–400 mm in
diameter), and a zone of hyperemia (250–500 mm in diam-
eter). The eschars were found on the waist and buttocks
region (four); lower extremities (two); upper extremities
and axillar region (two); and back, chest, neck, and
abdomen (one case each). In two patients, we noticed sub-
cutaneous lymphangitis and regional lymphadenopathy.
Initial conventional treatment at home, with a combination
of antipyretics, analgesics, and antibacterial therapy (oral
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Table 2. Serologic data of 11 patients with Rickettsia infection
a 
PCR  IgM tests 
Patient 
no. 
Disease 
onset date 
Antimicrobial 
treatment
b  gltA gene 
ompA and 
ompB genes  Sera 
Collection 
date  R. heilongjiangensis  R. hulinensis  R. sibirica  R. conorii 
1  6/24  0  0  0  0  1  6/18  6/23  +  NI 
2  6/28  1/32  1/32  1/32  1/32 
1  6/24  0  0  0  0  2  6/20  6/23  +  + 
2  7/9  0  0  0  0 
1  6/5  0  0  0  0  3  6/21  6/24  +  NI 
2  7/12  0  0  0  0 
1  6/26  1/32  1/16  1/16  1/32  4  6/22  6/26  +  NI 
2  7/1  1/64  1/64  1/64  1/64 
1  6/28  0  0  0  0  5  6/22  6/28  +  NI 
2  7/16  1/128  1/32  1/32  1/128 
1  7/3  0  0  0  0  6  6/29  7/2  +  + 
2  7/8  1/64  1/64  1/64  1/64 
1  7/5  0  0  0  0  7  6/30  7/4  +  NI 
2  7/16  1/1,024  1/1,024  1/256  1/1,024 
1  7/8  0  0  0  0  8  7/1  7/8  +  NI 
2  7/26  1/512  1/126  1/126  1/512 
1  7/15  1/64  1/64  1/64  1/64  9  7/6  7/12  +  NI 
2  7/31  1/128  1/128  1/128  1/128 
1  7/29  0  0  0  0  10  7/23  7/28  +  + 
2  8/13  1/32  1/32  1/16  1/16 
1  8/2  1/256  1/256  1/64  1/64  11  7/25  8/1  +  NI 
2  8/15  1/256  1/256  1/64  1/64 
aPCR, polymerase chain reaction; Ig, immunoglobulin; NI, not investigated. 
bDate of beginning of antimicrobial drug therapy. 
Figure 2. Phylogenetic tree, representing position of Rickettsia hei-
longjiangensis. The tree was made using MEGA 2.1 software after
alignment of both portions of ompA genes obtained from GenBank
and sequenced during this study by GENETIX-WIN 5.1 software.
The scale represents a number of substitutions per base per indi-
cated horizontal distance. The numbers present at nodes of the
tree represent the number of bootstrap replicates of 100 that dis-
play the indicated sequence groupings.penicillins) did not result in improvement; 5–9 days after
the onset of symptoms, all patients were admitted to the
hospital. They received oral doxycycline for 14 days and
antihistamine therapy, and clinical symptoms resolved
within 2 to 3 days. Laboratory tests in the hospital showed
elevated levels of serum transaminases (alanine amino-
transferase and aspartate aminotransferase) in 46% and
15% of patients, respectively, and these remained elevated
even during convalescence but were normal at follow-up at
3 to 4 weeks.
Discussion
Our findings suggest that patients had an acute infec-
tion with R. heilongjiangensis. Clinical data were typical
for acute rickettsial infections. We successfully amplified
four portions of three different rickettsial genes from
human blood and skin samples, which suggested the pres-
ence of this microorganism. We did not amplify any of
these genes in samples from healthy donors or from
patients suffering from other infectious diseases (negative
controls). The gltA gene is conservative, especially among
Rickettsia species (16), and ompA and ompB genes encode
main surface proteins of rickettsiae. These gene sequences
were completely homologous to the spotted fever group R.
heilongjiangensis. Previous GenBank sequences were
recently corrected (Fournier PE et al., unpub. data). The
identity of sequenced PCR products among patients, clini-
cal data, and epidemiologic data suggest the focality of this
rickettsiosis.
The serologic data support PCR and sequencing find-
ings. We showed that Rickettsia produces a clear immuno-
logic response in patients. We studied paired sera from
patients for reactivity with antigens of several species in
the Rickettsia genus, including R. heilongjiangensis and R.
hulinensis. Seroconversion, presence of IgM, or increasing
antibody titers were observed in most patients. In seven
cases, sera reacted at higher titers with antigen of R. hei-
longjiangensis when compared with R. sibirica, the only
currently identified tick-borne rickettsia in the Russian Far
East. In 77%, the titers were identical against R. hei-
longjiangensis and R. conorii antigens. Although serolog-
ic cross-reactions are common among rickettsiae of the
spotted fever group (26), the finding of lower titers against
the phylogenetically more closely related R. hulinensis
than the relatively more distant R. conorii was unexpected. 
Epidemiologic evidence of tick bite or exposure, rash,
primary lesion (eschar) at the site of tick bite, and rapid
recovery after doxycycline treatment support a rickettsial
cause for the disease. Some peculiarities were noticed
when signs were compared with infection caused by R.
sibirica in the Central Siberia. Seasonal peak of infections
is in the end of June and July. For Siberian tick typhus, the
seasonal peak is the end of April and May. The rash that
accompanies tick-borne rickettsiosis in the Russian Far
East is less obvious, and the disease apparently affects
older people than Siberian tick typhus. Only 1 of 13
patients was >45 years of age. Generally, the disease is
mild, with no serious complications or death recorded.
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Table 3. Serologic data of 11 patients with Rickettsia infection  
PCR  IgG tests 
Disease 
onset date 
Antimicrobial 
treatment
b  gltA gene 
ompA and  
ompB genes  Sera 
Collection 
date  R. heilongjiangensis  R. hulinensis  R. sibirica  R. conorii 
1  6/24  0  0  0  0  6/18  6/23  +  NI 
2  6/28  1/1024  1/512  1/512  1/1,024 
1  6/24  0  0  0  0  6/20  6/23  +  + 
2  7/9  0  0  0  0 
1  6/5  0  0  0  0  6/21  6/24  +  NI 
2  7/12  0  0  0  0 
1  6/26  1/64  1/64  1/64  1/64  6/22  6/26  +  NI 
2  7/1  1/2,048  1/512  1/512  1/2048 
1  6/28  0  0  0  0  6/22  6/28  +  NI 
2  7/16  1/128  1/128  1/128  1/128 
1  7/3  0  0  0  0  6/29  7/2  +  + 
2  7/8  1/128  1/64  1/64  1/128 
1  7/5  0  0  0  0  6/30  7/4  +  NI 
2  7/16  1/256  1/128  1/256  1/256 
1  7/8  0  0  0  0  7/1  7/8  +  NI 
2  7/26  0  0  0  0 
1  7/15  1/1,024  1/1,024  1/1,024  1/1,024  7/6  7/12  +  NI 
2  7/31  1/1,024  1/1,024  1/1,024  1/1,024 
1  7/29  0  0  0  0  7/23  7/28  +  + 
2  8/13  1/1,024  1/1,024  1/256  1/256 
1  8/2  1/256  1/256  1/128  1/128  7/25  8/1  +  NI 
2  8/15  1/256  1/256  1/128  1/128 
aPCR, polymerase chain reaction; Ig, immunoglobulin; NI, not investigated. 
bDate of beginning of antimicrobial drug therapy. The epidemiology of the disease remains mostly
unknown. Recently, DNA of the Rickettsia described in
our report was amplified from H. concinna ticks collected
in Siberia (S. Shpynov, unpub. data).
PCR-based technologies and direct sequencing provide
a fast and precise diagnosis or rickettsiosis. The preferable
method may be PCR on eschar biopsy samples because
this technique has high sensitivity and probability of find-
ing rickettsial DNA (27). Serologic studies of samples
from Russian Far East area should include tests with anti-
gens of R. heilongjiangensis. 
Results of our studies showed that acute febrile tick-
borne disease caused by R. heilongjiangensis is prevalent
in the Russian Far East. Molecular biology approaches
enabled us to identify the cause of an acute disease and to
detect its bacterial origin. As no evidence of R. sibirica
human infection was found in our study, further investiga-
tions are needed clarify its role in human pathology in the
Russian Far East, especially the Khabarovsk Region. 
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